Cargando...
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers
PURPOSE: Advanced cancers of the bile duct and gallbladder carry an ominous prognosis. Rebeccamycin analogue (RA) is a novel antitumor antibiotic where phase I trials suggested clinical efficacy in patients with biliary cancers. METHODS: The primary objective was to determine the response rate to RA...
Gardado en:
| Publicado en: | Cancer Chemother Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2009
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4220168/ https://ncbi.nlm.nih.gov/pubmed/19399502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-009-1005-x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|